Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.69%504.62M | -1.99%401.7M | 9.07%1.76B | -13.58%413.14M | 4.20%458.58M | 19.65%477.48M | 38.39%409.85M | 15.68%1.61B | 27.82%478.07M | 29.98%440.1M |
| Cost of revenue | 2.86%468.67M | -5.22%369.25M | 9.28%1.67B | -14.14%391.8M | 4.26%433.32M | 20.46%455.62M | 40.00%389.58M | 16.01%1.53B | 28.58%456.34M | 28.85%415.6M |
| Gross profit | 64.51%35.95M | 60.02%32.45M | 5.21%89.39M | -1.83%21.34M | 3.10%25.26M | 4.89%21.85M | 13.34%20.28M | 10.11%84.96M | 13.66%21.74M | 52.67%24.5M |
| Operating expense | 27.57%19.22M | 47.22%17.37M | 108.84%47.59M | -9.37%10.06M | 365.56%11.54M | 32.74%15.07M | 14.09%11.8M | -38.98%22.79M | -1.05%11.1M | -141.84%-4.34M |
| Selling and administrative expenses | 27.57%19.22M | 47.22%17.37M | 3.89%50.81M | -19.45%10.8M | -6.11%12.97M | 32.74%15.07M | 14.09%11.8M | 5.80%48.91M | 5.63%13.41M | 21.24%13.81M |
| -General and administrative expense | 27.57%19.22M | 47.22%17.37M | 3.89%50.81M | -19.45%10.8M | -6.11%12.97M | 32.74%15.07M | 14.09%11.8M | 5.80%48.91M | 5.63%13.41M | 21.24%13.81M |
| Total other operating income | ---- | ---- | -87.67%3.22M | -68.07%735K | -92.12%1.43M | ---- | ---- | 194.11%26.12M | 56.60%2.3M | 1,699.31%18.16M |
| Operating profit | 146.58%16.73M | 77.83%15.08M | -32.77%41.8M | 6.05%11.28M | -52.42%13.72M | -28.46%6.78M | 12.31%8.48M | 56.17%62.18M | 34.54%10.64M | 409.07%28.84M |
| Net non-operating interest income (expenses) | -23.29%-7.76M | -4.13%-5.88M | -2.72%-23.86M | 11.99%-5.66M | 0.09%-6.52M | -14.35%-6.29M | -18.42%-5.65M | -37.23%-23.23M | -52.95%-6.43M | -33.50%-6.53M |
| Non-operating interest income | 10.59%261K | -32.12%112K | -35.62%893K | 123.91%206K | -11.91%207K | -56.62%236K | -68.02%165K | -3.61%1.39M | -88.73%92K | 76.69%235K |
| Non-operating interest expense | 22.83%8.02M | 3.10%5.99M | 0.56%24.75M | -10.07%5.87M | -0.50%6.73M | 7.97%6.53M | 9.98%5.81M | 34.03%24.62M | 29.92%6.52M | 34.65%6.76M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 86.70%-1.27M | 145.61%1.85M | -94.68%-23.57M | -82.10%-6.85M | -11.32%-3.07M | -137.66%-9.54M | -157.36%-4.06M | -452.07%-12.11M | -79.51%-3.76M | -225.38%-2.76M |
| Less:Write off | -86.70%1.27M | -145.61%-1.85M | 94.68%23.57M | 82.10%6.85M | 11.32%3.07M | 137.66%9.54M | 157.36%4.06M | 452.07%12.11M | 79.51%3.76M | 225.38%2.76M |
| Other non-operating income (expenses) | 300.57%2.12M | 16.36%1.27M | -80.52%528K | -63.18%1.09M | ||||||
| Income before tax | 215.13%9.81M | 9,153.68%12.31M | -120.97%-5.63M | -374.89%-1.23M | -78.87%4.13M | -418.65%-8.52M | -103.27%-136K | 29.70%26.84M | -72.25%446K | 557.26%19.56M |
| Income tax | 328.68%3.28M | 953.45%3.06M | -69.11%1.48M | 39.73%2.05M | -56.17%554K | -259.75%-1.43M | -74.85%290K | -9.78%4.78M | 94.04%1.47M | 82.92%1.26M |
| Net income | 192.19%6.54M | 2,273.24%9.26M | -132.20%-7.1M | -221.20%-3.27M | -80.43%3.58M | -498.82%-7.09M | -114.17%-426K | 43.29%22.06M | -219.60%-1.02M | 700.70%18.3M |
| Net income continuous operations | 192.19%6.54M | 2,273.24%9.26M | -132.20%-7.1M | -221.20%-3.27M | -80.43%3.58M | -498.82%-7.09M | -114.17%-426K | 43.29%22.06M | -219.60%-1.02M | 700.70%18.3M |
| Noncontrolling interests | -4.94%1.35M | 106.92%2.81M | 450.93%8.03M | 103.78%2.81M | 2,991.14%2.44M | 141,500.00%1.42M | 1.36M | 1.46M | 1.38M | 79K |
| Net income attributable to the company | 161.02%5.19M | 461.12%6.45M | -173.43%-15.13M | -153.71%-6.08M | -93.75%1.14M | -578.73%-8.51M | -159.36%-1.79M | 33.82%20.61M | -381.22%-2.4M | 697.24%18.22M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 161.02%5.19M | 461.12%6.45M | -173.43%-15.13M | -153.71%-6.08M | -93.75%1.14M | -578.73%-8.51M | -159.36%-1.79M | 33.82%20.61M | -381.22%-2.4M | 697.24%18.22M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 160.00%0.003 | 500.00%0.004 | -169.23%-0.009 | -100.00%-0.004 | -91.67%0.001 | -600.00%-0.005 | -150.00%-0.001 | 30.00%0.013 | -1,100.00%-0.002 | 700.00%0.012 |
| Diluted earnings per share | 160.00%0.003 | 500.00%0.004 | -169.23%-0.009 | -100.00%-0.004 | -91.67%0.001 | -600.00%-0.005 | -151.98%-0.001 | 30.00%0.013 | -1,100.00%-0.002 | 700.00%0.012 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.76%0.0074 | 0.0044 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.